Cargando…

Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease

The mucopolysaccharidoses (MPS) are a group of diseases caused by the lysosomal accumulation of glycosaminoglycans, due to genetic deficiencies of enzymes involved in their degradation. MPS III or Sanfilippo disease, in particular, is characterized by early-onset severe, progressive neurodegeneratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heon-Roberts, Rachel, Nguyen, Annie L. A., Pshezhetsky, Alexey V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074161/ https://www.ncbi.nlm.nih.gov/pubmed/32012694 http://dx.doi.org/10.3390/jcm9020344

Ejemplares similares

Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023)

Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations
por: Matos, Liliana, et al.
Publicado: (2014)

Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches
por: Benetó, Noelia, et al.
Publicado: (2020)

Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Valstar, Marlies J, et al.
Publicado: (2011)

Mortality in patients with Sanfilippo syndrome
por: Lavery, Christine, et al.
Publicado: (2017)

How close are we to therapies for Sanfilippo disease?
por: Gaffke, Lidia, et al.
Publicado: (2017)

Natural history of Sanfilippo syndrome in Spain
por: Delgadillo, Verónica, et al.
Publicado: (2013)

Sanfilippo syndrome: causes, consequences, and treatments
por: Fedele, Anthony O
Publicado: (2015)

Divergent Roles of Vascular Burden and Neurodegeneration in the Cognitive Decline of Geriatric Depression Patients and Mild Cognitive Impairment Patients
por: Ye, Qing, et al.
Publicado: (2017)

Is the eye a window to the brain in Sanfilippo syndrome?
por: Beard, Helen, et al.
Publicado: (2020)

Sanfilippo syndrome: consensus guidelines for clinical care
por: Muschol, Nicole, et al.
Publicado: (2022)

Noradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia
por: Leanza, Giampiero, et al.
Publicado: (2018)

Analysis of the caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data
por: Shapiro, Elsa, et al.
Publicado: (2019)

Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain
por: Dintica, Christina S., et al.
Publicado: (2019)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-Related Cognitive Decline and Neurodegeneration
por: Flanagan, Emma, et al.
Publicado: (2018)

Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021)

Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach
por: Cyske, Zuzanna, et al.
Publicado: (2022)

Biochemical diagnosis of Sanfilippo disorder types A and B
por: Nosier, Soha S., et al.
Publicado: (2023)

Epidemiology of Sanfilippo syndrome: results of a systematic literature review
por: Zelei, Tamás, et al.
Publicado: (2018)

Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III)
por: Muschol, Nicole M., et al.
Publicado: (2019)

A case report of Sanfilippo syndrome – the long way to diagnosis
por: Lorenz, Delia, et al.
Publicado: (2022)

An immune deficient mouse model for mucopolysaccharidosis IIIA (Sanfilippo syndrome)
por: Pollock, Kari, et al.
Publicado: (2023)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017)

MRI load of cerebral microvascular lesions and neurodegeneration, cognitive decline, and dementia
por: Wang, Rui, et al.
Publicado: (2018)

Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer’s continuum
por: Kuhn, Elizabeth, et al.
Publicado: (2021)

The First Korean Case of Mucopolysaccharidosis IIIC (Sanfilippo Syndrome Type C) Confirmed by Biochemical and Molecular Investigation
por: Huh, Hee Jae, et al.
Publicado: (2013)

An Engineered sgsh Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA
por: Douek, Alon M., et al.
Publicado: (2021)

Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Mumford, Rachel A., et al.
Publicado: (2015)

Caregivers' assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome
por: Porter, Katherine Ackerman, et al.
Publicado: (2022)

Unusual Clinical Manifestations in a Mexican Patient with Sanfilippo B Syndrome
por: Fernández-Hernández, Liliana, et al.
Publicado: (2022)

N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndrome
por: De Pasquale, Valeria, et al.
Publicado: (2023)

Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
por: Ashby, Frederick James, et al.
Publicado: (2023)

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2018)

The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline
por: Cedres, Nira, et al.
Publicado: (2021)

Protein Misfolding as an Underlying Molecular Defect in Mucopolysaccharidosis III Type C
por: Feldhammer, Matthew, et al.
Publicado: (2009)

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
por: Trzeciakiewicz, Hanna, et al.
Publicado: (2020)

Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses
por: Kloska, Anna, et al.
Publicado: (2011)

Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann – Pick type C and Sanfilippo diseases
por: Dimitriou, Evangelia, et al.
Publicado: (2019)

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
por: Suárez‐Calvet, Marc, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6l1s7bbsav0uvqv0m36nbhqek4